Hepatitis C and liver transplantation
- PMID: 20011084
- PMCID: PMC2776333
Hepatitis C and liver transplantation
Abstract
Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in Europe, United States and Japan. Reinfection after liver transplantation is universal and chronic liver disease develops in at least 70% of patients at 3 years, with an accelerated course compared to the nontransplant setting. These facts underscore the need for a better understanding of hepatitis C infection and the various treatment modalities. This paper attempts a brief review of the scope of the disease, as well as the different treatment modalities, with special emphasis given to orthotopic liver transplantation.
Keywords: hepatitis C virus; hepatocellular carcinoma; orthotopic liver transplantation.
Similar articles
-
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.Nephrol Dial Transplant. 2007 Sep;22 Suppl 8:viii37-viii46. doi: 10.1093/ndt/gfm655. Nephrol Dial Transplant. 2007. PMID: 17890261 Review.
-
[Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].An Sist Sanit Navar. 2004;27 Suppl 2:91-101. An Sist Sanit Navar. 2004. PMID: 15381947 Review. Spanish.
-
Long-term outcome of hepatitis C virus infection after liver transplantation.Hepatology. 1997 Jan;25(1):203-10. doi: 10.1002/hep.510250137. Hepatology. 1997. PMID: 8985291
-
Management of recurrent hepatitis C virus after liver transplantation.World J Gastroenterol. 2014 Nov 28;20(44):16409-17. doi: 10.3748/wjg.v20.i44.16409. World J Gastroenterol. 2014. PMID: 25469009 Free PMC article. Review.
-
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment.World J Hepatol. 2015 Jul 18;7(14):1843-55. doi: 10.4254/wjh.v7.i14.1843. World J Hepatol. 2015. PMID: 26207166 Free PMC article. Review.
Cited by
-
Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.J Gastrointest Surg. 2018 Feb;22(2):344-360. doi: 10.1007/s11605-017-3562-3. Epub 2017 Sep 18. J Gastrointest Surg. 2018. PMID: 28924922 Review.
-
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up.J Clin Med. 2025 Jul 7;14(13):4801. doi: 10.3390/jcm14134801. J Clin Med. 2025. PMID: 40649175 Free PMC article. Review.
-
Revolution in the diagnosis and management of hepatitis C virus infection in current era.World J Hepatol. 2022 Apr 27;14(4):647-669. doi: 10.4254/wjh.v14.i4.647. World J Hepatol. 2022. PMID: 35646260 Free PMC article.
-
Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus.Open Access Maced J Med Sci. 2019 May 30;7(10):1641-1648. doi: 10.3889/oamjms.2019.459. eCollection 2019 May 31. Open Access Maced J Med Sci. 2019. PMID: 31210815 Free PMC article.
-
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection.World J Gastroenterol. 2018 Mar 28;24(12):1361-1372. doi: 10.3748/wjg.v24.i12.1361. World J Gastroenterol. 2018. PMID: 29599611 Free PMC article. Clinical Trial.
References
-
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359–362. - PubMed
-
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;25(5):558–567. - PubMed
-
- WHO Hepatitis C-global prevalence (update) Wkly Epidemiol Rec. 1999;74:425–427. - PubMed
-
- Thorburn D, Roy K, Wilson K, et al. Anonymous study of hepatitis C virus (HCV) prevalence in liver transplant surgeons. Liver Transpl. 2006;12:1084–1088. - PubMed
-
- Gogos CA, Fouka KP, Nikiforidis G, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18:551–557. - PubMed
LinkOut - more resources
Full Text Sources